This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Matthew Edwards and His Patent in Antibody Innovation.
Introduction
Matthew Edwards is an inventor associated with Collegeville, Pennsylvania, and GlaxoSmithKline Intellectual Property Development Limited. His recorded patent work concerns antibodies that bind to IL-33.
Latest Patents
Edwards is credited with 1 patent: “IL-33 Binding Antibodies.” The patent title identifies work involving antibodies that bind the IL-33 target.
Career Highlights
The available information connects Edwards’s invention to GlaxoSmithKline Intellectual Property Development Limited. His patent record highlights a contribution in antibody-related innovation.
Collaborations
Edwards’s listed coworkers include Martin Orecchia and Andrew Beaton.
Conclusion
Matthew Edwards’s recorded patent activity centers on IL-33-binding antibodies and reflects his association with GlaxoSmithKline Intellectual Property Development Limited.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile